Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia

NCT00726232 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

73

Enrollment

INDUSTRY

Sponsor class

Stopped Termination of the clinical trial by sponsor.

Conditions

Myeloproliferative Neoplasm (MPN)

Interventions

DRUG: Ruxolitinib

Sponsor

Incyte Corporation